BioLIVE China 2020

EXHIBITOR PROFILE

Biologics and New Therapies

• Recombinant Protein

• Polypeptide

• Nucleic Acid

• Vaccines

• Plasma

• Antibodies

• Cell and Gene Therapy

• Tumor Immunotherapy

• Stem Cell & iPS

Bioprocessing, Manufacturing and Solutions

• Cell Culture Media

• Biological Reagents

• Laboratory Consumables

• Bioreactors

• Bioseparation

• Protein Purification

• Bioprocessing

• Software and Service

Biotechnology and R&D services

• Molecular Biology

• Cell Biology

• Proteomics and Metabolomics

• Biotechnology Service Platform

• Detection Services

• Biology Information Services

• Drug R&D and Manufacturing

• Clinical Research

CONFERENCE REVIEW

Bio S&T

Bio S&T is a new platform combining conference and showcase for exchanges in new bio pharma science and technologies. With the support of the leading overseas organizations CABA, CABS and CBA, the event focused on the heated topics of Therapeutic mAbs, Biologicals GMP manufacturing and Biotechnology investment, and featured over 20 top-notch speakers and 120 industry elites from the global pharma society.

6th China bioLIVE Outlook Summit

The conference focused on the latest legislation and market data, interpreted the trends and directions of the R&D for biopharmaceuticals. Over 100 attended including government authorities, management and technical experts, consultants, property professionals gathered and discussed heatedly on the highlighted topics of the biopharma industry in China.

Workshop: Developing the BioPharma Workforce of the Future

This session was led by NIBRT, the global centre of excellence for training and research in bioprocessing. Bringing their expertise to China for the first time, this session featured a presentation from NIBRT on global biopharma workforce challenges, case studies from their Partners, and a look at existing training programmes in China and Australia.